Douglas W. Kingma

5.8k total citations · 1 hit paper
59 papers, 4.3k citations indexed

About

Douglas W. Kingma is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Douglas W. Kingma has authored 59 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 32 papers in Oncology and 17 papers in Immunology. Recurrent topics in Douglas W. Kingma's work include Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (31 papers) and Eosinophilic Disorders and Syndromes (9 papers). Douglas W. Kingma is often cited by papers focused on Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (31 papers) and Eosinophilic Disorders and Syndromes (9 papers). Douglas W. Kingma collaborates with scholars based in United States, Hungary and United Kingdom. Douglas W. Kingma's co-authors include Elaine S. Jaffe, Mark Raffeld, Julie Teruya‐Feldstein, Shimareet Kumar, Timothy R. Coté, James J. Goedert, Robert J. Biggar, Mitchell H. Gail, Mary M. Horowitz and Rochelle E. Curtis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Douglas W. Kingma

59 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spectrum of AIDS-associated malignant disorders

1998 539 citations Douglas W. Kingma, Elaine S. Jaffe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas W. Kingma United States	36	2.4k	1.9k	1.2k	777	622	59	4.3k
Risa B. Mann United States	39	2.8k 1.1×	3.1k 1.6×	826 0.7×	562 0.7×	913 1.5×	77	5.6k
Fiona E. Craig United States	29	1.4k 0.6×	1.4k 0.7×	1.2k 1.0×	666 0.9×	801 1.3×	104	4.0k
Joseph A. DiGiuseppe United States	31	1.5k 0.6×	1.0k 0.5×	1.2k 0.9×	603 0.8×	554 0.9×	69	4.9k
Daina Variakojis United States	36	1.4k 0.6×	1.9k 1.0×	780 0.6×	433 0.6×	690 1.1×	120	4.1k
Keisei Kawa Japan	35	2.1k 0.9×	1.2k 0.7×	1.8k 1.5×	490 0.6×	1.8k 2.9×	109	4.6k
Kazimiera J. Gajl‐Peczalska United States	28	1.5k 0.6×	1.2k 0.7×	890 0.7×	483 0.6×	446 0.7×	40	3.2k
Jean‐Pierre Clauvel France	26	1.3k 0.5×	807 0.4×	825 0.7×	950 1.2×	420 0.7×	63	4.0k
Markus Tiemann Germany	36	2.1k 0.9×	2.4k 1.3×	767 0.6×	238 0.3×	351 0.6×	134	4.3k
Bruce Patterson Canada	32	1.2k 0.5×	1.3k 0.7×	972 0.8×	333 0.4×	919 1.5×	59	3.7k
John K.C. Chan China	39	2.3k 1.0×	2.6k 1.4×	768 0.6×	766 1.0×	162 0.3×	102	5.6k

Countries citing papers authored by Douglas W. Kingma

Since Specialization

Citations

This map shows the geographic impact of Douglas W. Kingma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Kingma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Kingma more than expected).

Fields of papers citing papers by Douglas W. Kingma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas W. Kingma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Kingma. The network helps show where Douglas W. Kingma may publish in the future.

Co-authorship network of co-authors of Douglas W. Kingma

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W. Kingma. A scholar is included among the top collaborators of Douglas W. Kingma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W. Kingma. Douglas W. Kingma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allen, Richard A., et al.. (2011). Comparison of 2 line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas. Diagnostic Microbiology and Infectious Disease. 70(2). 240–245. 4 indexed citations

Kingma, Douglas W., Richard A. Allen, Melissa K. Melby, et al.. (2010). Comparison of Molecular Methods for Detection of HPV in Oral and Oropharyngeal Squamous Cell Carcinoma. Diagnostic Molecular Pathology. 19(4). 218–223. 11 indexed citations

Ahmad, Ejaz, Douglas W. Kingma, Elaine S. Jaffe, et al.. (2005). Flow cytometric immunophenotypic profiles of mature gamma delta T‐cell malignancies involving peripheral blood and bone marrow. Cytometry Part B Clinical Cytometry. 67B(1). 6–12. 35 indexed citations

Sorbara, Lynn, Douglas W. Kingma, Mark Raffeld, et al.. (2003). Minimal Residual Disease Detection in Hairy Cell Leukemia. American Journal of Clinical Pathology. 119(2). 213–217. 48 indexed citations

Barry, Todd, Elaine S. Jaffe, Douglas W. Kingma, et al.. (2002). CD5+ Follicular Lymphoma. American Journal of Clinical Pathology. 118(4). 589–598. 37 indexed citations

Teruya‐Feldstein, Julie, Douglas W. Kingma, Andrew Weiss, et al.. (2001). Chemokine Gene Expression and Clonal Analysis of B Cells in Tissues Involved by Lymphoid Interstitial Pneumonitis from HIV-Infected Pediatric Patients. Modern Pathology. 14(10). 929–936. 13 indexed citations

Caffrey, Michael, Demetrios T. Braddock, John M. Louis, et al.. (2000). Biophysical Characterization of gp41 Aggregates Suggests a Model for the Molecular Mechanism of HIV-associated Neurological Damage and Dementia. Journal of Biological Chemistry. 275(26). 19877–19882. 25 indexed citations

Rowlings, Philip A., Rochelle E. Curtis, Jakob Passweg, et al.. (1999). Increased Incidence of Hodgkin's Disease After Allogeneic Bone Marrow Transplantation. Journal of Clinical Oncology. 17(10). 3122–3127. 61 indexed citations

Jaffe, Elaine S., László Krenács, Shimareet Kumar, Douglas W. Kingma, & Mark Raffeld. (1999). Extranodal peripheral T-cell and NK-cell neoplasms.. PubMed. 111(1 Suppl 1). S46–55. 116 indexed citations

10.

Teruya‐Feldstein, Julie, Elaine S. Jaffe, Parris R. Burd, et al.. (1999). Differential Chemokine Expression in Tissues Involved by Hodgkin’s Disease: Direct Correlation of Eotaxin Expression and Tissue Eosinophilia. Blood. 93(8). 2463–2470. 109 indexed citations

11.

Elenitoba‐Johnson, Kojo S.J., Abelardo Meneses, László Krenács, et al.. (1998). Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.. PubMed. 11(8). 754–61. 71 indexed citations

12.

Kumar, Shimareet, L. Jeffrey Medeiros, Kojo S.J. Elenitoba‐Johnson, et al.. (1998). Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Human Pathology. 29(4). 397–403. 145 indexed citations

13.

Natkunam, Yasodha, Kojo S.J. Elenitoba‐Johnson, Douglas W. Kingma, & Onsi W. Kamel. (1997). Epstein‐Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases. Arthritis & Rheumatism. 40(6). 1152–1156. 7 indexed citations

14.

Levin, Michael C., Tanya Lehky, David Katz, et al.. (1997). Immunologic Analysis of a Spinal Cord–Biopsy Specimen from a Patient with Human T-Cell Lymphotropic Virus Type I–Associated Neurologic Disease. New England Journal of Medicine. 336(12). 839–845. 61 indexed citations

15.

Kingma, Douglas W., Maria Tsokos, Thierry Fest, et al.. (1996). Epstein-Barr Virus (EBV)-associated Smooth-muscle Tumor Arising in a Post-transplant Patient Treated Successfully for Two PT-EBV-associated Large-cell Lymphomas. The American Journal of Surgical Pathology. 20(12). 1511–1519. 54 indexed citations

16.

Kamel, Onsi W., Lawrence M. Weiss, Matt van de Rijn, et al.. (1996). Hodgkin's Disease and Lymphoproliferations Resembling Hodgkin's Disease in Patients Receiving Long-Term Low-Dose Methotrexate Therapy. The American Journal of Surgical Pathology. 20(10). 1279–1287. 94 indexed citations

17.

Medeiros, L. Jeffrey, et al.. (1994). Malignant Lymphomas of B-Cell Lineage with Marked Tissue Eosinophilia. The American Journal of Surgical Pathology. 18(4). 347–356. 26 indexed citations

18.

Kumar, Shimareet, Dhruv Kumar, Douglas W. Kingma, & Elaine S. Jaffe. (1993). Epstein-Barr VirusAssociated T-Cell Lymphoma in a Renal Transplant Patient. The American Journal of Surgical Pathology. 17(10). 1046–1053. 40 indexed citations

19.

Kingma, Douglas W., et al.. (1991). Selective Type II Muscle Fiber Hypertrophy in Severe Infantile Spinal Muscular Atrophy. Journal of Child Neurology. 6(4). 329–334. 12 indexed citations

20.

Simons, Richard J. & Douglas W. Kingma. (1989). Fatal colchicine toxicity. The American Journal of Medicine. 86(3). 356–357. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact